Outcomes of photodynamic therapy with a half dose of verteporfin in patients with chronic central serous chorioretinopathy

dc.contributor.authorTürkcü F.M.
dc.contributor.authorYüksel H.
dc.contributor.authorŞahin A.
dc.contributor.authorÇinar Y.
dc.contributor.authorCingü K.
dc.contributor.authorŞahin M.
dc.contributor.authorYildirim A.
dc.date.accessioned2024-04-24T18:43:41Z
dc.date.available2024-04-24T18:43:41Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractPurpose: To evaluate the effectiveness and the results of photodynamic therapy (PDT) with half the dose verteporfin in chronic central serous chorioretinopathy (CSCR). Materials and Methods: Nineteen eyes of 19 patients diagnosed with chronic CSCR were included in the study. The diagnoses were made by fundus fluorescein angiography and optical coherence tomography (OCT). Corrected logMAR visual acuity (VA) and central macular thickness (CMT) were analyzed before and after treatment. The baseline and the sixth month results were compared. Results: The mean age of the patients was 37.4±6.1 and 16 (84.2%) of them were male, 3 (15.8%) of them were female. The mean follow-up time was 7.9±2.2 (6-12) months. After PDT, 15 (78.9%) of cases gained minimum one line increase in VA. In three (15.8%) patients visual acuity remained unchanged and in a patient (5.3%) VA decreased one line. There was a significant reduction (p = 0,001) in the mean CMT values when compared before and after PDT. Subretinal fluid in OCT resolved completely in 17 (89.4%) patients and partially in one (5.3%) patients but it showed an increase only in one patient (5.3%). There was not any complication due to PDT in any patients. Conclusion: Photodynamic therapy with a half the dose verteporfin was considered as an effective treatment in the patients with chronic CSCR.en_US
dc.identifier.endpage278en_US
dc.identifier.issn1300-1256
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84892636424en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage274en_US
dc.identifier.urihttps://hdl.handle.net/11468/24286
dc.identifier.volume21en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofRetina-Vitreusen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCentral Serous Chorioretinopathyen_US
dc.subjectPhotodynamic Therapyen_US
dc.subjectVerteporfinen_US
dc.titleOutcomes of photodynamic therapy with a half dose of verteporfin in patients with chronic central serous chorioretinopathyen_US
dc.title.alternativeKronik santral seröz koryoretinopatili olgularda yarim doz verteporfin ile uygulanan fotodinamik tedavi sonuçlarien_US
dc.typeArticleen_US

Dosyalar